DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Vials Market – Distribution by Type of Fabrication Material Used, Sterilization Status and Key Geographies – Industry Trends and Global Forecasts, 2021-2030” report has been added to ResearchAndMarkets.com’s offering.
Over the years, advances in drug / therapy development processes have led the pharmaceutical industry to gradually shift from a one-drug treats all model to a more personalized approach of treatment. The growing complexity of modern pharmacological interventions, such as monoclonal antibodies, and cell and gene therapies, has further prompted the drug developers to develop or identify specialized fill / finish and packaging alternatives that are capable of catering to the specific needs of such novel products.
Pharmaceutical packaging, owing to the fact that it is in immediate contact with the drug / therapy formulation, plays a vital role in preserving the identity, quality and integrity of the packaged medicinal product. Although there are various types of primary packaging containers, including ampoules, cartridges and syringes, available in the market for various types of drug formulations, pharmaceutical vials have been observed to be the preferred choice of drug developers, owing to the fact that they provide high container-closure integrity.
Despite being the most preferred packaging system, traditional vials are often associated with certain challenges, including chances of breakage under extreme conditions, absence of relevant information (serial or batch number) on the package and potential to delaminate. As a result, several pharmaceutical vial manufacturers are exploring novel techniques to overcome the aforementioned challenges associated with conventional pharmaceutical vials in order to create better packaging solutions. Examples of some advancements in this domain include the use of serialization techniques (to avoid drug counterfeiting), development of numerous coating materials.
Key Questions Answered
- Who are the leading players engaged in the manufacturing of pharmaceutical vials?
- What is the relative competitiveness of different pharmaceutical vial manufacturers?
- What type of partnership models are commonly adopted by industry stakeholders engaged in this industry?
- What is the current, global demand for pharmaceutical vials?
- What are the emerging trends related to pharmaceutical primary packaging?
- What are the factors that are likely to influence the growth of the pharmaceutical vials market?
- How is the current and future opportunity likely to be distributed across key market segments?
Report Scope
- A detailed assessment of the current market landscape of pharmaceutical vials, featuring information on the type of fabrication material used for container (glass and plastic),type of fabrication material used for closure (rubber, plastic and metal), volume of vial (less than 50 ml, 50 ml to 100 ml and more than 100 ml), type of vial cap (screw cap, crimp cap and snap cap), sterilization status (pre-sterilized and unsterilized), type of product (untreated and treated), compatible drug class (biologics and small molecules) and type of formulation stored (liquid, powder and solid). In addition, the chapter includes analysis related to pharmaceutical vial manufacturers based on various parameters, including year of establishment, company size, location of headquarters and key players (in terms of number of products).
- A competitiveness analysis of pharmaceutical vial manufacturers, segmented into four categories, namely small (1-50 employees), mid-sized companies (51-500 employees), and large (501-1,000 employees) and very large companies (more than 1,000 employees). Within the peer group, companies were ranked based on various relevant parameters, such as supplier power (based on the experience / expertise of the manufacturer) and key product specifications (type of fabrication material used, type of vial cap, sterilization status, type of product, compatible drug class and type of formulation stored).
- Elaborate profiles of prominent players engaged in the development of pharmaceutical vials, based in North America, Europe and Asia Pacific. Each profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook.
- An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2015-2021 (till September), covering acquisitions, product / technology integration agreements, supply agreements, asset acquisitions, distribution agreements, product / technology development agreements, product / technology licensing agreements, and other related agreements. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of fabrication material involved, sterilization status, type of partners and regional distribution of the collaborations.
- An elaborate discussion on the key trends (such as the advent of personalized / targeted therapies, shift towards more flexible packaging, rise of modular manufacturing facilities and advancement in robotic packaging solutions) that are likely to have an impact on the future adoption of innovative primary packaging systems. It also features a harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.
Companies Mentioned
- ABB
- Abdos Labtech
- Acme Vial and Glass
- ADIT Containers
- Afton Scientific
- Agrado
- ALK Life Science Solutions
- Allergy Laboratories
- Amatsigroup (Acquired by Eurofins CDMO)
- Amber Hydrometers
- Amcor
- Anhui Huaxin pharmaceutical glass products
- Aptar CSP Technologies
- Aptar Pharma
- Arab Pharmaceutical Glass
- ARaymondlife
- Argos Technologies
- Aseptic Technologies
- Automated Systems of Tacoma (AST)
- Azer Scientific
- Berkshire Sterile Manufacturing
- Bespak
- BioCision
- Biologix
- Bormioli Pharma
- Borosil
- Bosch Packaging Technology
- And Many More Companies
For more information about this report visit https://www.researchandmarkets.com/r/1yyz6l
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900